COVID-19 vaccine acceptance climbed from 75% in 2021 to 79% in 2022 in 23 countries representing nearly 60% of the global population, finds a survey published yesterday in Nature Medicine.
...
In eight countries, however, vaccine hesitancy increased (range, 1.0% in the United Kingdom to 21.1% in South Africa). And nearly 1 in 8 of all respondents (12.1%), particularly those aged 18 to 29 years, said they were hesitant to receive a booster dose (range, 1.1% in China to 28.9% in Russia).
Confirmed COVID-19 cases are currently nowhere near where they were during the last two winters in the U.S., but they are expected to rise. The current numbers reported are also believed to be lower than they actually are since more people are testing at home.
A pair of new studies describe infection- and vaccine-conferred immunity against the SARS-CoV-2 Omicron variant, with one showing that vaccinated people have good protection against BA.5 subvariant reinfection for at least 8 months after infection, and the other finding that the vaccine is 46% and 70% effective against infection and hospitalization, respectively, in children.
... WHO executive director for health emergencies Mike Ryan said the numbers released by China “under-represent the true impact of the disease” in terms of hospital and ICU admissions, as well as deaths.
Recent Comments